Results 221 to 230 of about 79,054 (352)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity

British Journal of Pharmacology, EarlyView.
Background and Purpose Dopamine receptor agonists, particularly targeting the dopamine D2L receptor (D2LR), have been used to treat Parkinson's disease (PD). However, valvular heart disease and somnolence, mainly caused by activating the serotonin 5‐HT2B receptor (5‐HT2BR) and dopamine D3 receptor (D3R), respectively, currently challenge their clinical
Takayuki Suzuki, Fumiki Oana, Masaki Oota, Yuma Handa, Osamu Kaminuma   +4 more
wiley   +1 more source

<b>Investigating the Association of Blackboard Teaching with Scapular Dyskinesia and Shoulder Pain Among School Teachers in Karachi, Pakistan</b>

Mohammad Khalid, Maira Muneer, Okasha Anjum   +2 more
openalex   +2 more sources

Expansion of the Phenotypic and Genotypic Spectrum for PRKAR1B‐Related Marbach–Schaaf Neurodevelopmental Syndrome: A Case Series

Clinical Genetics, EarlyView.
Comprehensive clinical description of 12 subjects with pathogenic PRKAR1B variants, including two heterozygous deletions supporting haploinsufficiency as a possible mechanism of disease, providing valuable insight into the pathophysiology of MASNS and setting a framework upon which to design future mechanistic studies of PKA signaling in brain ...
Sebastian Burkart, Tarik Guzeloglu, Ana R. Soares, Irene Valenzuela, Eduardo F. Tizzano, David Gómez‐Andres, Laurent Pasquier, Marine Legendre, Camille Berges, Julien Thevenon, Marjolaine Gauthier, Caleb Heid, Elly Ranum, Joseph Shen, Michelle Frees, Michael W. Schmidtke, Caro Pilar, Christian P. Schaaf   +17 more
wiley   +1 more source

Novel homozygous <i>C3orf67</i> gene variant associated with primary ciliary dyskinesia in a Saudi pediatric patient: A case report. [PDF]

World J Exp Med
Alkhadidi F, AlSharif H, AlQthami A, Alkhaldi SH, Alsuwat SA, Abosabie SA, Abosabie SA, Kamal NM.   +7 more
europepmc   +1 more source

PERSISTENT DYSKINESIA AFTER LONG-TERM TREATMENT WITH NEUROLEPTICS IN JAPAN

, 1976
Gohei Yagi, Kazuhiro Ogita, Nobuo Ohtsuka, Hitoshi Itoh, Sadanori Miura   +4 more
openalex   +2 more sources

Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease.

American Journal of Respiratory and Critical Care Medicine, 2013
M. Knowles, L. A. Daniels, S. Davis, M. Zariwala, M. Leigh   +4 more
semanticscholar   +1 more source

Beyond bacteria and breaking the norm: Pulmonary mucormycosis due to <i>Absidia corymbifera</i> in a child with primary ciliary dyskinesia. [PDF]

J Int Med Res
Alghamdi AO, AlKhadidi FJ, Alawur AH, Alkhaldi S, Habib L, Alharbe R, Algethami AS, Aljaed NM, Abosabie SA, Abosabie SA, Kamal NM.   +10 more
europepmc   +1 more source

Cerebral perfusion imaging predicts levodopa-induced dyskinesia in Parkinsonian rat model [PDF]

Jarrad Perron, Sophia Krak, Samuel Booth, Dali Zhang, Ji Hyun Ko   +4 more
openalex   +1 more source

Implant Therapy in Patients With Neurodegenerative Diseases—A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The increasing longevity of populations has resulted in a growing number of older adults requiring prosthodontic care, including those with neurodegenerative diseases (NDs). Neurodegenerative diseases pose significant challenges to prosthodontic care, and it remains unclear whether implant therapy in this population achieves ...
Lysandre David, Sabrina Maniewicz, Najla Chebib, Gabriel Gold, Murali Srinivasan, Frauke Müller   +5 more
wiley   +1 more source

An Update on Tardive Dyskinesia: From Phenomenology to Treatment

, 2013
Olga Waln, Joseph Jankovic
openalex   +2 more sources